Compounds > fullerene c60
Page last updated: 2024-09-03

fullerene c60 and paclitaxel

fullerene c60 has been researched along with paclitaxel in 4 studies

Compound Research Comparison

Studies
(fullerene c60)		Trials
(fullerene c60)		Recent Studies (post-2010)
(fullerene c60)		Studies
(paclitaxel)		Trials
(paclitaxel)		Recent Studies (post-2010) (paclitaxel)
3,80652,17031,8745,72915,395

Protein Interaction Comparison

ProteinTaxonomyfullerene c60 (IC50)paclitaxel (IC50)
Integrin beta-3Homo sapiens (human)0.034
Integrin alpha-V Homo sapiens (human)0.034
ATP-dependent translocase ABCB1Homo sapiens (human)2.598
Botulinum neurotoxin type A Clostridium botulinum5.2
UDP-glucuronosyltransferase 2B7Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1-6Homo sapiens (human)4.9
Substance-K receptorHomo sapiens (human)6.125
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1A4Homo sapiens (human)4.9
UDP-glucuronosyltransferase 2B10 Homo sapiens (human)4.9
Delta-type opioid receptorHomo sapiens (human)4.202
Tyrosine-protein kinase MerHomo sapiens (human)4.9
Tubulin beta-3 chainHomo sapiens (human)0.0082
Beta-tubulin Leishmania donovani1
Nucleotide-binding oligomerization domain-containing protein 2Homo sapiens (human)7.9433
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)0.26
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.28

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilbert, BE; Knight, V; Seryshev, A; Sitharaman, B; Wilson, LJ; Zakharian, TY1
Conyers, JL; Joshi, PP; Lyon, JL; Mitchell, LR; Partha, R1
Domb, AJ; Levy, Y; Mandler, D; Tal, N; Tzemach, G; Weinberger, J1
Alamdari, A; Alimohammadi, M; Dahri Dahroud, M; Maleki, R; Rezaian, M1

Other Studies

4 other study(ies) available for fullerene c60 and paclitaxel

ArticleYear
A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture.
    Journal of the American Chemical Society, 2005, Sep-14, Volume: 127, Issue:36

    Topics: Aerosols; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Drug Screening Assays, Antitumor; Fullerenes; Humans; Liposomes; Lung Neoplasms; Molecular Structure; Paclitaxel; Tissue Culture Techniques

2005
Buckysomes: fullerene-based nanocarriers for hydrophobic molecule delivery.
    ACS nano, 2008, Sep-23, Volume: 2, Issue:9

    Topics: Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Fullerenes; Humans; Hydrophobic and Hydrophilic Interactions; Nanostructures; Paclitaxel

2008
Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer.
    Journal of biomedical materials research. Part B, Applied biomaterials, 2009, Volume: 91, Issue:2

    Topics: Adhesiveness; Angioplasty, Balloon; Animals; Antineoplastic Agents, Phytogenic; Benzene Derivatives; Blood Vessels; Cell Adhesion; Cell Survival; Coated Materials, Biocompatible; Diazonium Compounds; Drug-Eluting Stents; Electric Impedance; Electrochemistry; Fullerenes; Hemolysis; In Vitro Techniques; Materials Testing; Metals; Microscopy, Electron, Scanning; Paclitaxel; Polymers; Rabbits; Spectrometry, X-Ray Emission

2009
pH-Sensitive Co-Adsorption/Release of Doxorubicin and Paclitaxel by Carbon Nanotube, Fullerene, and Graphene Oxide in Combination with
    Biomolecules, 2018, 10-29, Volume: 8, Issue:4

    Topics: Acrylamides; Adsorption; Doxorubicin; Drug Carriers; Drug Liberation; Fullerenes; Graphite; Hydrogen Bonding; Hydrogen-Ion Concentration; Molecular Dynamics Simulation; Nanotubes, Carbon; Paclitaxel; Static Electricity; Thermodynamics

2018